CN113499416A - 一种补肝益肾组合物及其制备方法 - Google Patents
一种补肝益肾组合物及其制备方法 Download PDFInfo
- Publication number
- CN113499416A CN113499416A CN202111028361.3A CN202111028361A CN113499416A CN 113499416 A CN113499416 A CN 113499416A CN 202111028361 A CN202111028361 A CN 202111028361A CN 113499416 A CN113499416 A CN 113499416A
- Authority
- CN
- China
- Prior art keywords
- parts
- kidney
- liver
- effects
- tonifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003734 kidney Anatomy 0.000 title claims abstract description 71
- 210000004185 liver Anatomy 0.000 title claims abstract description 60
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 230000000694 effects Effects 0.000 claims abstract description 52
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 33
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 33
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 33
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 23
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 23
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 23
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 21
- 240000000249 Morus alba Species 0.000 claims abstract description 21
- 241000222336 Ganoderma Species 0.000 claims abstract description 20
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 20
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 20
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 19
- 241000237502 Ostreidae Species 0.000 claims abstract description 19
- 235000020636 oyster Nutrition 0.000 claims abstract description 19
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 17
- 235000011477 liquorice Nutrition 0.000 claims abstract description 17
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 16
- 238000010025 steaming Methods 0.000 claims abstract description 16
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 15
- 235000013976 turmeric Nutrition 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 13
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 241000336291 Cistanche deserticola Species 0.000 claims abstract description 9
- 238000007873 sieving Methods 0.000 claims abstract description 9
- 241000169546 Lycium ruthenicum Species 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims abstract description 5
- 244000182216 Mimusops elengi Species 0.000 claims abstract 6
- 239000002245 particle Substances 0.000 claims description 31
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 23
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 21
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 15
- 235000008584 Hovenia dulcis Nutrition 0.000 claims description 13
- 244000010000 Hovenia dulcis Species 0.000 claims description 13
- 235000017803 cinnamon Nutrition 0.000 claims description 13
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 6
- 240000008397 Ganoderma lucidum Species 0.000 claims description 6
- 244000235659 Rubus idaeus Species 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 235000014375 Curcuma Nutrition 0.000 claims description 3
- 210000003813 thumb Anatomy 0.000 claims description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims 3
- 241000675108 Citrus tangerina Species 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 50
- 239000008280 blood Substances 0.000 abstract description 50
- 239000003814 drug Substances 0.000 abstract description 27
- 210000004072 lung Anatomy 0.000 abstract description 20
- 206010011224 Cough Diseases 0.000 abstract description 17
- 210000000952 spleen Anatomy 0.000 abstract description 17
- 235000013399 edible fruits Nutrition 0.000 abstract description 11
- 229940079593 drug Drugs 0.000 abstract description 10
- 230000004438 eyesight Effects 0.000 abstract description 10
- 230000001603 reducing effect Effects 0.000 abstract description 8
- 230000001105 regulatory effect Effects 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 7
- 210000002784 stomach Anatomy 0.000 abstract description 7
- 210000005036 nerve Anatomy 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 230000027939 micturition Effects 0.000 abstract description 4
- 206010000060 Abdominal distension Diseases 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 230000008093 supporting effect Effects 0.000 abstract description 3
- 235000019605 sweet taste sensations Nutrition 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 230000004087 circulation Effects 0.000 abstract 1
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 239000000686 essence Substances 0.000 description 31
- 235000009508 confectionery Nutrition 0.000 description 19
- 240000002624 Mespilus germanica Species 0.000 description 17
- 235000019640 taste Nutrition 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 240000007651 Rubus glaucus Species 0.000 description 15
- 210000002216 heart Anatomy 0.000 description 15
- 239000000126 substance Substances 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 241000723347 Cinnamomum Species 0.000 description 10
- 241001672694 Citrus reticulata Species 0.000 description 10
- 235000012754 curcumin Nutrition 0.000 description 10
- 239000004148 curcumin Substances 0.000 description 10
- 229940109262 curcumin Drugs 0.000 description 10
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 230000009471 action Effects 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 230000007935 neutral effect Effects 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 206010016256 fatigue Diseases 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 210000003127 knee Anatomy 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 7
- 241000005787 Cistanche Species 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- 208000005392 Spasm Diseases 0.000 description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 240000008866 Ziziphus nummularia Species 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 208000007848 Alcoholism Diseases 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- 208000031975 Yang Deficiency Diseases 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 201000007930 alcohol dependence Diseases 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 201000001881 impotence Diseases 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000010228 Erectile Dysfunction Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 206010047513 Vision blurred Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- -1 anthraquinone compounds Chemical class 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000002110 toxicologic effect Effects 0.000 description 3
- 231100000759 toxicological effect Toxicity 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N 2-Amino-2-Deoxy-Hexose Chemical compound NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 235000011511 Diospyros Nutrition 0.000 description 2
- 244000236655 Diospyros kaki Species 0.000 description 2
- 235000003333 Diospyros lotus Nutrition 0.000 description 2
- 244000022372 Diospyros lotus Species 0.000 description 2
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 235000008586 Hovenia Nutrition 0.000 description 2
- 241000405398 Hovenia Species 0.000 description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 208000001140 Night Blindness Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241001468611 Polygonatum cyrtonema Species 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- 206010040007 Sense of oppression Diseases 0.000 description 2
- 241000208292 Solanaceae Species 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- FZPYMZUVXJUAQA-ZDUSSCGKSA-N Turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-ZDUSSCGKSA-N 0.000 description 2
- FZPYMZUVXJUAQA-UHFFFAOYSA-N Turmerone Natural products CC(C)=CC(=O)CC(C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-UHFFFAOYSA-N 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 235000012665 annatto Nutrition 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- MDKCFLQDBWCQCV-UHFFFAOYSA-N benzyl isothiocyanate Chemical compound S=C=NCC1=CC=CC=C1 MDKCFLQDBWCQCV-UHFFFAOYSA-N 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000004727 humoral immunity Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 150000003408 sphingolipids Chemical class 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- UEPVWRDHSPMIAZ-IZTHOABVSA-N (1e,4z,6e)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-IZTHOABVSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- BLCJBICVQSYOIF-UHFFFAOYSA-N 2,2-diaminobutanoic acid Chemical compound CCC(N)(N)C(O)=O BLCJBICVQSYOIF-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 244000017106 Bixa orellana Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241001481833 Coryphaena hippurus Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- QRMPRVXWPCLVNI-UHFFFAOYSA-N Curcumenol Natural products C1C(=C)C2CCC(C)C22CC(C(C)C)C1(O)O2 QRMPRVXWPCLVNI-UHFFFAOYSA-N 0.000 description 1
- HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 1
- 241000723267 Diospyros Species 0.000 description 1
- 235000008597 Diospyros kaki Nutrition 0.000 description 1
- 244000055850 Diospyros virginiana Species 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000007984 Female Infertility Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241001489091 Ganoderma sinense Species 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010021928 Infertility female Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000218213 Morus <angiosperm> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- QAADZYUXQLUXFX-UHFFFAOYSA-N N-phenylmethylthioformamide Natural products S=CNCC1=CC=CC=C1 QAADZYUXQLUXFX-UHFFFAOYSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- ZVKOASAVGLETCT-UOGKPENDSA-N Norbixin Chemical compound OC(=O)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O ZVKOASAVGLETCT-UOGKPENDSA-N 0.000 description 1
- JERYLJRGLVHIEW-UENHKZIGSA-N Norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=CC=CC(=O)O JERYLJRGLVHIEW-UENHKZIGSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000308150 Orobanchaceae Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000037826 Polygonatum kingianum Species 0.000 description 1
- 241000037831 Polygonatum sibiricum Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 241000123889 Rubus chingii Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- ZVKOASAVGLETCT-UOAMSCJGSA-N all-trans norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=C(/C)C=CC(=O)O ZVKOASAVGLETCT-UOAMSCJGSA-N 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- 239000001670 anatto Substances 0.000 description 1
- 239000010362 annatto Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- ISFMXVMWEWLJGJ-NZBPQXDJSA-N curcumenol Chemical compound CC1=C[C@](O2)(O)C(=C(C)C)C[C@@]22[C@@H](C)CC[C@H]21 ISFMXVMWEWLJGJ-NZBPQXDJSA-N 0.000 description 1
- ZVMJXSJCBLRAPD-UHFFFAOYSA-N curzerenone Chemical compound C1C(C=C)(C)C(C(=C)C)C(=O)C2=C1OC=C2C ZVMJXSJCBLRAPD-UHFFFAOYSA-N 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- NMRUIRRIQNAQEB-UHFFFAOYSA-N demethoxycurcumin Natural products OC(=CC(C=CC1=CC(=C(C=C1)O)OC)=O)C=CC1=CC=C(C=C1)O NMRUIRRIQNAQEB-UHFFFAOYSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 1
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 210000002332 leydig cell Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000003887 myelocyte Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- UEPVWRDHSPMIAZ-UHFFFAOYSA-N p-hydroxycinnamoyl feruloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(O)=CC(=O)C=CC=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-UHFFFAOYSA-N 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000003431 steroids Chemical group 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000011121 vaginal smear Methods 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/44—Ebenaceae (Ebony family), e.g. persimmon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中草药技术领域,公开了一种补肝益肾组合物及其制备方法。该组合物是以枸杞滋补肝肾,益精明目;黑枸杞清肺热,镇咳消炎;肉苁蓉补肾助阳;玛咖滋补强身;灵芝补气安神,免疫调节;黄精补脾益气,滋肾填精;橘红理气宽中;姜黄活血行气;甘草益气补中、调和药性;肉桂补火助阳;牡蛎养血安神;黑枣补中益气、补血调理;枳椇子健胃补血,滋养补血;桑椹滋阴补血;覆盆子固精缩尿,益肝肾明目。该组合物是以味甘、性平温的药物为主,益肾兴阳、补益肝肾的有效成分为主的方剂。制备方法通过利用的对原料进行蒸制、过筛的方法使原料中的有效成分得到最大程度的析出,糊化处理的成品为膏状,便于储存、服用,无任何毒副作用,具有安全性。
Description
技术领域
本发明属于中草药技术领域,具体涉及一种补肝益肾组合物及其制备方法。
背景技术
现代都市上班族普遍使用电脑办公,烟酒不离,夜生活不节制,熬夜,这些生活习惯都在直接影响并伤害着肝、肾。中医认为肝主目:“肝气通于目,肝和则目能辨五色矣”。肝的病变往往影响及目。如肝血不足,则两目干涩,视物不清或夜盲;肝经风热,可见目赤痒痛;肝火上炎,可见目赤生翳;肝阳上亢,则头目眩晕;肝风内动,可见目斜上视等。《黄帝内经》的“五劳所伤”中有一伤:“久视伤血“。这里的血,指的就是肝血。眼睛与肝脏联系紧密。肝藏血,即肝脏具有贮藏血液和调节血量的功能,而且肝开窍于目。双眼受到血的给养才能视物,而过度用眼,会使肝血亏虚,使双目得不到营养的供给,从而出现眼干涩、看东西模糊、夜盲等。另外,长期久坐用眼,除双目供血不足外,颈椎、腰椎也会产生劳损,总得不到缓解,也会对肝脏造成损害。这种情况下,出现双眼疲劳、视力下降,甚至面色萎黄,头晕眼花的症状。
肾藏先后天之精,肾精化为肾气,其中对机体有温煦、激发、兴奋、蒸化、封藏和制约阴寒等作用者称之为肾阳,亦称为元阳、真阳、真火;对机体有滋润、宁静、成形和抑制过度阳热等作用者称之为肾阴,亦称为元阴、真阴、真水。肾阳能促进人体的新陈代谢即气化过程,促进精血津液的化生并使之转化为能量,使人体各种生理活动的进程加快,产热增加,精神振奋;肾阴则抑制或减缓人体的过度的新陈代谢过程,使精血津液转化为能量减少,人体各种生理活动的进程减慢,产热相对减少,并使气聚成形而为精血津液,精神也趋于宁静内守二者相反相成,共同调节控制着人体的脏腑功能活动和精血津液的代谢过程。
按照中医学的阴阳理论,阴阳具有无限可分性,肾藏先后天之精,精属阴,所以称阴精,气属阳,所以称阳气,合称阴精阳气。肾精属阴精,阴精之中又可再分阴阳,其中又可分为阴精中之阳精和阴精中之阴精。阴精中之阳精亏虚时,有腰膝酸痛、夜尿频多、腰脊萎弱、骨酸疲惫、易疲劳等症状表现,阴精中之阴精亏虚时有腰膝酸软、足跟痛、口干舌燥、消渴、失眠多梦等症状表现。阴精中之阳精亏虚时多与肾阳虚关系密切,阴精中之阴精亏虚时多与肾阴虚关系密切。所以肾阳虚时除了有畏寒怕冷等表现外常伴有腰膝酸痛、腰脊萎弱、骨酸疲惫、易疲劳等症状,肾阴虚时除了有阴虚燥热等表现外常伴有腰膝酸软、足跟痛、口干舌燥、消渴等症状临床表现为腰膝酸痛,畏寒肢冷,尤以下肢为甚,头目眩晕,精神萎靡,面色白;或黎黑,舌淡胖苔白,脉沉弱;或男子阳痿,早泄,妇女宫寒不孕,或大便久泄不止,完谷不化,五更泄泻;或浮肿,腰以下为甚,按之凹陷不起,甚则腹部胀痛,心悸咳喘。所以补肾阳的时候,一定要补肾阴,而且要阴中求阳,而且在补肾阴的时候也不是一味的只用补肾阴的药物
目前市场上补肝益肾的保健品或是药物有很多,但是大多数保健品的价格十分昂贵,常人无法持续服用,而普通药物的效果并不是十分的好,大多数药物都不具备从根本上为人体健康护航的作用,往往进行简单的缓解。
发明内容
为了解决现有技术存在的上述问题,本发明目的在于提供一种补肝益肾组合物及其制备方法。
本发明所采用的技术方案为:一种补肝益肾组合物,所述组合物主要由以下质量份数的原料制备得到:
枸杞5-15份,黑枸杞5-12份,肉苁蓉10-15份,玛咖10-15份,灵芝6-12份,黄精10-15份,橘红3-10份,姜黄3-10份,甘草2-6份,肉桂2-5份,牡蛎3-10份,黑枣10-15份,枳椇子9-15份,桑椹10-15份和覆盆子5-10份。
枸杞,中药名。为茄科植物宁夏枸杞LyciumbarbarumL.的成熟果实。具有滋补肝肾,益精明目的功效。主治肝肾阴虚及早衰证。味甘,性平;归肝、肾、肺经。化学成分:本品含甜菜碱、多糖、粗脂肪、粗蛋白、硫胺素、核黄素、烟酸、胡萝卜素、抗坏血酸、烟酸、β-谷甾醇、亚油酸、微量元素及氨基酸等成分。药理作用:枸杞子对免疫有促进作用,同时具有免疫调节作用;可提高血睾酮水平,起强壮作用;对造血功能有促进作用;对正常健康人也有显著升白细胞作用;还有抗衰老、抗突变、抗肿瘤、降血脂、保肝及抗脂肪肝、降血糖、降血压作用。毒理作用:枸杞毒性很小。甜菜碱进入体内以原形排出,大鼠静注2.4g/kg,未见毒性反应。小鼠腹腔注射25g/kg,10min内出现全身痉挛,呼吸停止。枸杞水提取物小鼠皮下注射的LD50为8.32g/kg,而甜菜碱为18.78g/kg,表明前者毒性较后者大1倍多。
黑枸杞,中药名。为茄科植物黑枸杞LyciumruthenicumMurr.的根皮或果实。具有清肺热,镇咳,消炎的功效。主治哮喘性气管炎,止咳,牙龈出血,感冒,咳嗽,发烧。味苦,性寒。化学成分:果含有机酸、维生素、糖类。
肉苁蓉,中药名。为列当科肉苁蓉属植物肉苁蓉CistanchedeserticolaY.C.Ma带鳞叶的肉质茎。具有补肾助阳,润肠通便的功效。主治肾阳亏虚,精血不足,阳痿早泄,宫冷不育,腰膝酸痛,痿软无力,肠燥津枯便秘。味甘、咸,性温;归肾、大肠经。
玛咖,(学名:LepidiummeyeniiWalp)可食用,是一种纯天然食品,营养成份丰富。玛卡富含高单位营养素,对人体有滋补强身的功用。黑色玛卡是被公认为效果最好的玛卡,产量极少。颜色较深的玛卡根,如红色、紫色、黑色,含有较多的碘,黑色玛卡被认为是强壮与精力的代表,口感上兼顾了甜与微苦。玛卡干根中的玛卡化学组成成份:蛋白质含量为10%以上(胡宁湖畔的玛卡品种的蛋白质含量超过14%),59%的碳水化合物;8.5%的纤维,内含丰富的锌、钙、铁、钛、铷、钾、钠、铜、锰、镁、锶、磷、碘等矿物质,并含有维生素C、B1、B2、B6、A、E、B12、B5,脂肪含量不高但其中多为不饱和脂肪酸,亚油酸和亚麻酸的含量达53%以上,天然活性成份:包括生物碱、芥子油苷及其分解产物异硫氰酸苄酯、甾醇、多酚类物质等。1999年,美国科学家发现了玛卡中含有两类新的植物活性成份,玛卡酰胺(macamides)和玛卡稀(macaenes),并确定这两种物质对平衡人体荷尔蒙分泌有显著作用,所以玛卡又被称为天然荷尔蒙发动机。在玛卡产品的针对性研究中,又发现了几种特殊的玛卡生物碱,随着研究的深入,玛卡中还会有更多的具有活性的新物质被分离和鉴定。玛卡富含高单位营养素,对人体有滋补强身的功用,食用过的人会有体力充沛、精神旺盛不会疲劳的感觉。
灵芝,中药名。为多孔菌科灵芝属真菌赤芝Ganodermalucidum(Leyss.ex Fr.)Karst.或紫芝Ganodermasinense Zhao,Xu et Zhang的干燥子实体。具有补气安神,止咳平喘的功效。主治心神不宁,失眠,惊悸,咳喘痰多,虚劳证等。味甘,性平;归心、肺、肝、肾经。化学成分:本品含多糖、核苷类、呋喃类、甾醇类、生物碱、三萜类、油脂类、多种氨基酸及蛋白质类、酶类、有机锗及多种微量元素等。药理作用:灵芝多糖具有免疫调节、降血糖、降血脂、抗氧化、抗衰老及抗肿瘤作用;三萜类化合物能净化血液,保护肝功能;灵芝多种制剂分别具有镇静、抗惊厥、强心、抗心律失常、降压、镇咳平喘作用;此外,灵芝还有抗凝血、抑制血小板聚集及抗过敏作用。毒理作用:灵芝毒性较小,小鼠腹腔注射赤芝渗漉液LD50为38.3±1.04g/kg,赤芝热醇提取液腹腔注射,小鼠的LD50为6.75g/kg,灌胃的MLD为165g/kg,冷醇提取液毒性更小,每日给大鼠灌胃1.2g/kg及12g/kg,共30天,对生长发育、肝功能、心电图等均无中毒表现。
黄精,中药名。为百合科黄精属植物黄精Polygonatumsibiricum Red.、多花黄精Polygonatumcyrtonema Hua或滇黄精Polygonatumkingianum Coll.et Hemsl.的干燥根茎。具有养阴润肺,补脾益气,滋肾填精的功效。主治阴虚劳嗽,肺燥咳嗷,脾虚乏力,食少口干,消渴;肾亏腰膝酸软,阳痿遗精,耳鸣目暗,须发早白,体虚羸瘦,风癞癣疾。味甘,性平;归脾、肺、肾经。化学成分:含黏液质、淀粉、糖、烟酸、醌类。多花黄精含二氨基丁酸、天门冬氨酸、高丝氨酸、毛地黄糖苷及多种蒽醌类化合物。药理作用:黄精具有抗病原微生物、降血脂、延缓衰老及其他作用,对心血管系统、免疫功能和环核苷酸含量、血糖均有影响。
橘红,中药名。为芸香科植物橘CitrusreticulataBlanco及其栽培变种的干燥外层果皮。味辛、苦,性温。归肺、脾经。功能:理气宽中,燥湿化痰。主治:用于咳嗽痰多,食积伤酒,呕恶痞闷。橘红,中药名。为芸香科植物橘CitrusreticulataBlanco及其栽培变种的干燥外层果皮。秋末冬初果实成熟后采收,用刀削下外果皮,晒干或阴干。味辛、苦,性温。归肺、脾经。功能:理气宽中,燥湿化痰。主治:用于咳嗽痰多,食积伤酒,呕恶痞闷。《药品化义》:橘红,辛能横行散结,苦能直行下降,为利气要药。盖治痰须理气,气利痰自愈,故用入肺脾,主一切痰病,功居诸痰药之上。佐竹茹以疗热呃,助青皮以导滞气,同苍术、厚朴平胃中之实,合葱白、麻黄表寒湿之邪,消谷气,解酒毒,止呕吐,开胸膈痞塞,能推陈致新,皆辛散苦降之力也。
姜黄,中药名。为姜科姜黄属植物姜黄Curcuma longa L.的干燥根茎。具有活血行气,通经止痛的功效。主治气滞血瘀痛证,风湿痹痛。味辛、苦,性寒;归肝、胆、心包经。化学成分:含有挥发油,主要成分:为姜黄酮、芳姜黄酮、姜烯、水芹烯、香桧烯、桉油素、莪术酮、莪术醇、丁香烯龙脑、樟脑等;色素物,主要为姜黄素、去甲氧基姜黄素;以及胭脂树橙和降胭脂树素和微量元素等。药理作用:姜黄素能抑制血小板聚集,降低血浆黏度和全血黏度;水煎剂、姜黄粉石油醚、乙醇和水提物有抗早孕作用;姜黄素、水提物及有效成分有抗肿瘤作用;姜黄素、醇或醚提取物和挥发油能降血脂;姜黄素又有抗炎作用;姜黄素对细菌有抑制作用,而挥发油则对真菌有强力的抑制作用;姜黄提取物、姜黄素、挥发油、姜黄酮以及姜烯、龙脑和倍半萜烯等都能利胆;姜黄素有短而强烈的降压作用,对离体豚鼠心脏有抑制作用;姜黄素能保护胃黏膜,保护肝细胞。毒理作用大鼠口服姜黄素5g/kg,外观无明显嘉性作用。
甘草,中药名。为豆科甘草属植物植物甘草GlycyrrhizauralensisFisch.、胀果甘草Glycyrrhizainflata Bat.或光果甘草Glycyrrhizaglabra L.的干燥根和根茎。具有益气补中,润肺止咳,清热解毒,缓急止痛,调和药性的功效。主治脾虚倦怠,心虚悸动,咳嗽气喘,痈疽喉痹,药食中毒,脘腹、四肢挛急疼痛等。味甘,性平;归心、肺、脾经。
肉桂,中药名。为樟科樟属植物肉桂Cinnamomum cassia Presl的干燥树皮。具有补火助阳,散寒止痛,活血通经的功效。用于肾阳不足,阳痿宫冷,眩晕目赤,心腹冷痛,寒痹腰痛,寒疝奔豚,寒凝血瘀,经闭痛经,阴疽流注等。味辛、甘,性大热;归肾、脾、心经。
牡蛎,肉中富含蛋白质,每百克新鲜牡蛎肉含11.3克,其蛋白质不只氨基酸的组成成分全面,还具有相当数量的牛磺酸,胜过人乳和牛乳。归经:心;肝经,功效:养血安神;软坚消肿。考证:出自《本草纲目拾遗》。主治:烦热失眠;悯神不安;瘰疬。性味:味甘;咸;性平。富含10种必需氨酸1.3%,无机盐(铜、锌、锰、钡、磷、钙)17.6%,谷胱甘肽(Glutathione),维生素A、B1、B2、D及F(即亚麻酸和亚油酸)。含碘1-11.53ppm(干重)。脂类中含一种糖脂,其糖由二分子葡萄糖和一分子岩藻糖构成。另有一种鞘类磷脂(Sphingo-lipid),含糖(葡萄糖、阿拉伯糖、岩藻糖)22.O%,氨基己糖(Hexosamine)7.26%,甲基戊糖(Methylpentose)10.45%,磷0.47%。
黑枣,学名君迁子(DiospyrosIotus Linn),属柿树科、柿属,别名软枣、牛奶枣、野柿子、丁香枣、圆脑子等,仅分布于中国北方地区,主要分为有核和无核两种(无核为人工嫁接品种),主要的品种有大核黑枣、牛奶枣和葡萄黑枣等。黑枣能补中益气,养胃健脾,养血壮神,润心肺,调营卫、生津液,悦颜色,通九窍,助十二经,解药毒,调和百药。黑枣入脾胃经,能补中益气、养血、安神及明目。多用于补血和作为调理药物,对贫血、血小板减少、肝炎、乏力、失眠有一定疗效。野生大黑枣,药用干品,大约180-130颗/斤。根据现代药理研究:黑枣含有葡萄糖、果糖、蔗糖、维生素c、核黄素、胡萝卜素、13种氨基酸和36种微量元素等,堪称“天然的综合维生素丸”,对于少年阶段视力保健有极佳的效果。作用功效:1、黑枣的作用能提高人体免疫力,并可抑制癌细胞:药理研究发现,红枣能促进白细胞的生成,降低血清胆固醇,提高血清白蛋白,保护肝脏,红枣中还含有抑制癌细胞,甚至可使癌细胞向正常细胞转化的物质;2、黑枣的作用经常食用鲜枣的人很少患胆结石:这是因为鲜枣中丰富的维生素C,使体内多余的胆固醇转变为胆汁酸。胆固醇少了,结石形成的概率也就随之减少;3、黑枣的作用枣中富含钙和铁,它们对防治骨质疏松产贫血有重要作用:中老年人更年期经常会骨质疏松,正在生长发育高峰的青少年和女性容易发生贫血,大枣对他们会有十分理想的食疗作用,其效果通常是药物不能比拟的;4、黑枣的作用对病后体虚的人也有良好的滋补作用。5、枣所含的芦丁,是一种使血管软化,从而使血压降低的物质,对高血压病有防治功效;6、枣还可以抗过敏、除腥臭怪味、宁心安神、益智健脑、增强食欲。
枳椇子,中药名。为鼠李科枳模属植物拐枣HoveniadulcisThunb.,以树皮与种子入药。具有子:清热利尿,止咳除烦,解酒毒。树皮:活血,舒筋解毒。果梗:健胃,补血。主治子:用于热病烦渴,呕吐,小便不利,酒精中毒。树皮:用于腓肠肌痉挛,食积,铁棒锤中毒。果梗:蒸熟浸酒,作滋养补血用。性味归经:味甘,性平。主治:1、子:用于热病烦渴,呕吐,小便不利,酒精中毒。2、树皮:用于腓肠肌痉挛,食积,铁棒锤中毒。3、果梗:蒸熟浸酒,作滋养补血用。
桑椹,中药名。为桑科桑属植物桑Morus alba L.的果穗。具有滋阴补血,生津润肠的功效。主治眩晕耳鸣,须发早白,血虚经闭,津伤口渴,内热消渴,肠燥便秘等。味甘、酸,性寒;归心、肝、肾经。化学成分:含芸香苷、花青素苷、胡萝卜素、维生素B1、维生素B2、维生素C及糖类。尚含脂肪油,其中主要成分为亚油酸、少量硬脂酸和油酸。药理作用:1、对免疫系统的影响:对细胞免疫和体液免疫功能均有增强作用。2、促进淋巴细胞转化的作用:100%桑椹煎剂有中度激发淋巴细胞转化的作用。3、促进造血机能的作用:可促进造血细胞生长,并对粒系祖细胞的生长有促进作用。4、升高外周血细胞的作用:桑椹可能有防止环磷酰胺所致饿白细胞减少症的作用。5、此外,桑椹尚有一定的促进T淋巴细胞成熟、降低红细胞膜Na-K-ATP酶活性等作用。
覆盆子,中药名。为蔷薇科悬钩子属植物华东覆盆子Rubuschingii Hu的未成熟果实。具有固精缩尿,益肝肾明目的功效。主治肾气不足,下元虚冷而致遗精、滑精、遗尿、尿频、阳痿、不孕,以及肝肾不足,两目昏花,视物不清等。味甘、酸,性微温;归肝、肾经。覆盆子含有机酸、糖类及少量维生素C,果实中还含有三萜成分、覆盆子酸、鞣花酸和β-谷甾醇。1、抗病原微生物作用:覆盆子煎剂对葡萄球菌、霍乱弧菌有抑制作用。2、对免疫系统的影响:覆盆子的4种提取组分——水提取液、醇提取液、粗多糖和正丁醇均有明显的促进淋巴细胞增殖作用,不论有无丝裂原ConA辅助,覆盆子都具有激活淋巴细胞的作用。3、对生殖系统的影响:覆盆子水提液直接作用于睾丸Leydig细胞,能提高甾体合成酶活性,抑制其酶分解,使合成睾酮能力增强,血液睾酮水平升高。以兔的阴道涂片及内膜切片作观察指标,覆盆子似有雌激素样作用。
作为优选地,所述组合物主要由以下质量份数的原料制备得到:
枸杞8-13份,黑枸杞6-10份,肉苁蓉11-14份,玛咖11-14份,灵芝8-10份,黄精11-14份,橘红5-8份,姜黄5-8份,甘草3-5份,肉桂2.5-4份,牡蛎5-8份,黑枣11-14份,枳椇子10-13份,桑椹11-14份和覆盆子7-9份。
作为优选地,所述组合物主要由以下质量份数的原料制备得到:
枸杞10份,黑枸杞8份,肉苁蓉12份,玛咖12份,灵芝9份,黄精12份,橘红6份,姜黄6份,甘草4份,肉桂3份,牡蛎6份,黑枣12份,枳椇子12份,桑椹12份和覆盆子8份。
一种补肝益肾组合物的制备方法,所述方法包括如下步骤:
按照相应比例选取枸杞、黑枸杞、肉苁蓉、黄精、姜黄、肉桂、黑枣和枳椇子混合后进行蒸制,过筛网,得到提取液;
按照相应比例选取玛咖、灵芝、橘红、甘草、牡蛎、桑椹和覆盆子混合、研碎后,与上述提取液混合,糊化、灭菌、冷却后,获得成品。
作为优选地,所述蒸制温度为90-120摄氏度。
作为优选地,所述蒸制时长为3-6小时。
作为优选地,所述过100-200目筛网。
作为优选地,所述玛咖、灵芝、橘红、甘草、牡蛎、桑椹和覆盆子混合、研碎后,粒径均为30-80mm。
作为优选地,所述糊化温度为80-90摄氏度;
所述糊化时长为20-35分钟。
作为优选地,所述成品为内服制剂。
本发明的有益效果为:
本发明提供了一种补肝益肾组合物,该组合物是以枸杞,味甘,性平,归肝、肾、肺经,滋补肝肾,益精明目,免疫调节;黑枸杞,味苦,性寒,清肺热,镇咳消炎;肉苁蓉,味甘、咸,性温,归肾、大肠经,补肾助阳;玛咖,滋补强身,体力充沛、精神旺盛不会疲劳;灵芝,味甘,性平,归心、肺、肝、肾经,补气安神,免疫调节,抗氧化,强心;黄精,味甘,性平,归脾、肺、肾经,养阴润肺,补脾益气,滋肾填精;橘红,味辛、苦,性温,归肺、脾经,理气宽中,燥湿化痰;姜黄,味辛、苦,性寒,归肝、胆、心包经,活血行气,抑菌强心;甘草,味甘,性平,归心、肺、脾经,益气补中,润肺止咳,清热解毒,缓急止痛,调和药性;肉桂,味辛、甘,性大热,归肾、脾、心经,补火助阳,散寒止痛,活血通经;牡蛎,归心、肝经,养血安神;黑枣,入脾胃经,能补中益气、养血、安神及明目,补血调理,滋补;枳椇子,味甘,性平,健胃补血,滋养补血;桑椹,味甘、酸,性寒,归心、肝、肾经,滋阴补血,增强细胞免疫和体液免疫;覆盆子,味甘、酸,性微温,归肝、肾经,固精缩尿,益肝肾明目。该组合物是以味甘、性平温的药物为主,益肾兴阳、补益肝肾的有效成分为主的方剂。
该方剂的制备方法通过利用的对原料进行蒸制、过筛的方法使原料中的有效成分得到最大程度的析出,进而以糊化完成成品,糊化处理的成品为膏状,便于储存,便于服用,无任何毒副作用,具有安全性。
具体实施方式
下面结合具体实施例对本发明做进一步阐释。本领域技术人员将会理解,下列所描述的实施例是本发明一部分实施例,而不是全部的实施例,仅用于说明本发明,而不应视为限制本发明的范围。所用试剂均为可以通过市售购买获得的常规产品。
实施例1:
一种补肝益肾组合物的制备方法,方法包括如下步骤:
按照相应比例选取枸杞5克、黑枸杞5克、肉苁蓉10克、黄精10克、姜黄3克、肉桂2克、黑枣10克和枳椇子9克混合后,在90摄氏度下进行蒸制6小时,过100目筛网,得到提取液;
按照相应比例选取玛咖(粒径为30mm)10克、灵芝(粒径为30mm)6克、橘红(粒径为30mm)3克、甘草(粒径为30mm)2克、牡蛎(粒径为30mm)3克、桑椹(粒径为30mm)10克和覆盆子(粒径为30mm)5克混合、研碎后,与上述提取液混合,在80摄氏度下糊化35分钟、灭菌、冷却后,获得成品。
实施例2:
一种补肝益肾组合物的制备方法,方法包括如下步骤:
按照相应比例选取枸杞15克、黑枸杞12克、肉苁蓉15克、黄精15克、姜黄10克、肉桂5克、黑枣15克和枳椇子15克混合后,在120摄氏度下进行蒸制3小时,过200目筛网,得到提取液;
按照相应比例选取玛咖(粒径为80mm)15克、灵芝(粒径为80mm)12克、橘红(粒径为80mm)10克、甘草(粒径为80mm)6克、牡蛎(粒径为80mm)10克、桑椹(粒径为80mm)15克和覆盆子(粒径为80mm)10克混合、研碎后,与上述提取液混合,在90摄氏度下糊化20分钟、灭菌、冷却后,获得成品。
实施例3:
一种补肝益肾组合物的制备方法,方法包括如下步骤:
按照相应比例选取枸杞8克、黑枸杞6克、肉苁蓉11克、黄精11克、姜黄5克、肉桂2.5克、黑枣11克和枳椇子10克混合后,在90摄氏度下进行蒸制6小时,过100目筛网,得到提取液;
按照相应比例选取玛咖(粒径为30mm)11克、灵芝(粒径为30mm)8克、橘红(粒径为30mm)5克、甘草(粒径为30mm)3克、牡蛎(粒径为30mm)5克、桑椹(粒径为30mm)11克和覆盆子(粒径为30mm)7克混合、研碎后,与上述提取液混合,在80摄氏度下糊化35分钟、灭菌、冷却后,获得成品。
实施例4:
一种补肝益肾组合物的制备方法,方法包括如下步骤:
按照相应比例选取枸杞13克、黑枸杞10克、肉苁蓉14克、黄精14克、姜黄8克、肉桂4克、黑枣14克和枳椇子13克混合后,在120摄氏度下进行蒸制3小时,过200目筛网,得到提取液;
按照相应比例选取玛咖(粒径为80mm)14克、灵芝(粒径为80mm)10克、橘红(粒径为80mm)8克、甘草(粒径为80mm)5克、牡蛎(粒径为80mm)8克、桑椹(粒径为80mm)14克和覆盆子(粒径为80mm)9克混合、研碎后,与上述提取液混合,在90摄氏度下糊化20分钟、灭菌、冷却后,获得成品。
实施例5:
一种补肝益肾组合物的制备方法,方法包括如下步骤:
按照相应比例选取枸杞10克、黑枸杞8克、肉苁蓉12克、黄精12克、姜黄6克、肉桂3克、黑枣12克和枳椇子12克混合后,在90摄氏度下进行蒸制6小时,过100目筛网,得到提取液;
按照相应比例选取玛咖(粒径为80mm)12克、灵芝(粒径为80mm)9克、橘红(粒径为80mm)6克、甘草(粒径为80mm)4克、牡蛎(粒径为80mm)6克、桑椹(粒径为80mm)12克和覆盆子(粒径为80mm)8克混合、研碎后,与上述提取液混合,在80摄氏度下糊化35分钟、灭菌、冷却后,获得成品。
使用方式:可采用冲服的方式,或是含服的方式均可。每日服用不超过30g。
本发明不局限于上述可选的实施方式,任何人在本发明的启示下都可得出其他各种形式的产品,均属于本发明的保护范围。上述具体实施方式不应理解成对本发明的保护范围的限制,本领域的普通技术人员应当理解,在不背离本发明的范围下,可对前述各实施例所记载的技术方案进行修改,或对其中部分或者全部技术特征进行等同替换,与此同时这些修改或者替换,并不会使相应的技术方案的本质脱离本发明各实施例技术方案的范围。
Claims (10)
1.一种补肝益肾组合物,其特征在于,所述组合物主要由以下质量份数的原料制备得到:
枸杞5-15份,黑枸杞5-12份,肉苁蓉10-15份,玛咖10-15份,灵芝6-12份,黄精10-15份,橘红3-10份,姜黄3-10份,甘草2-6份,肉桂2-5份,牡蛎3-10份,黑枣10-15份,枳椇子9-15份,桑椹10-15份和覆盆子5-10份。
2.根据权利要求1所述的一种补肝益肾组合物,其特征在于,所述组合物主要由以下质量份数的原料制备得到:
枸杞8-13份,黑枸杞6-10份,肉苁蓉11-14份,玛咖11-14份,灵芝8-10份,黄精11-14份,橘红5-8份,姜黄5-8份,甘草3-5份,肉桂2.5-4份,牡蛎5-8份,黑枣11-14份,枳椇子10-13份,桑椹11-14份和覆盆子7-9份。
3.根据权利要求2所述的一种补肝益肾组合物,其特征在于,所述组合物主要由以下质量份数的原料制备得到:
枸杞10份,黑枸杞8份,肉苁蓉12份,玛咖12份,灵芝9份,黄精12份,橘红6份,姜黄6份,甘草4份,肉桂3份,牡蛎6份,黑枣12份,枳椇子12份,桑椹12份和覆盆子8份。
4.一种如权利要求1-3任一所述的补肝益肾组合物的制备方法,其特征在于,所述方法包括如下步骤:
按照相应比例选取枸杞、黑枸杞、肉苁蓉、黄精、姜黄、肉桂、黑枣和枳椇子混合后进行蒸制,过筛网,得到提取液;
按照相应比例选取玛咖、灵芝、橘红、甘草、牡蛎、桑椹和覆盆子混合、研碎后,与上述提取液混合,糊化、灭菌、冷却后,获得成品。
5.根据权利要求4所述的一种补肝益肾组合物制备方法,其特征在于,所述蒸制温度为90-120摄氏度。
6.根据权利要求5所述的一种补肝益肾组合物制备方法,其特征在于,所述蒸制时长为3-6小时。
7.根据权利要求4所述的一种补肝益肾组合物制备方法,其特征在于,所述过100-200目筛网。
8.根据权利要求4所述的一种补肝益肾组合物制备方法,其特征在于,所述玛咖、灵芝、橘红、甘草、牡蛎、桑椹和覆盆子混合、研碎后,粒径均为30-80mm。
9.根据权利要求4所述的一种补肝益肾组合物制备方法,其特征在于,所述糊化温度为80-90摄氏度;
所述糊化时长为20-35分钟。
10.根据权利要求4所述的一种补肝益肾组合物制备方法,其特征在于,所述成品为内服制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111028361.3A CN113499416A (zh) | 2021-09-02 | 2021-09-02 | 一种补肝益肾组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111028361.3A CN113499416A (zh) | 2021-09-02 | 2021-09-02 | 一种补肝益肾组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113499416A true CN113499416A (zh) | 2021-10-15 |
Family
ID=78016330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111028361.3A Pending CN113499416A (zh) | 2021-09-02 | 2021-09-02 | 一种补肝益肾组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113499416A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106492110A (zh) * | 2016-11-08 | 2017-03-15 | 中国科学院过程工程研究所 | 一种解酒组合物、包含其的解酒护肝制剂及其应用 |
CN106929349A (zh) * | 2015-12-31 | 2017-07-07 | 九芝堂股份有限公司 | 一种酒及其制备方法 |
CN110423668A (zh) * | 2018-04-28 | 2019-11-08 | 高洪举 | 一种桑葚酒及其制作方法 |
CN111990508A (zh) * | 2020-09-17 | 2020-11-27 | 傅松涛 | 一种益精茶及其制备方法 |
-
2021
- 2021-09-02 CN CN202111028361.3A patent/CN113499416A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106929349A (zh) * | 2015-12-31 | 2017-07-07 | 九芝堂股份有限公司 | 一种酒及其制备方法 |
CN106492110A (zh) * | 2016-11-08 | 2017-03-15 | 中国科学院过程工程研究所 | 一种解酒组合物、包含其的解酒护肝制剂及其应用 |
CN110423668A (zh) * | 2018-04-28 | 2019-11-08 | 高洪举 | 一种桑葚酒及其制作方法 |
CN111990508A (zh) * | 2020-09-17 | 2020-11-27 | 傅松涛 | 一种益精茶及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN104381691A (zh) | 用于预防仔猪营养不良性贫血的功能性饲料及其制备方法 | |
CN110354204B (zh) | 一种具有明目功效的组合物及其制备、应用方法 | |
CN103405728B (zh) | 一种治疗更年期综合症的中药组合物及其制备方法 | |
CN101612315A (zh) | 一种用于调整人体机能的中药复方制剂 | |
CN107648454A (zh) | 一种补肾膏滋及其制备方法 | |
CN103555530A (zh) | 百合保健药酒 | |
CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN107751993A (zh) | 一种抗疲劳膏滋及其制备方法 | |
KR20090127970A (ko) | 생식환의 조성물 및 이의 제조 방법 | |
CN110075266A (zh) | 一种养肾固肾补气血的配方及制备方法 | |
CN103610077A (zh) | 一种海参胶囊 | |
CN103238757B (zh) | 一种含发酵棉粕的蛋鸡配合饲料及其制备方法 | |
CN104544084B (zh) | 一种用于糖尿病患者的保健食品 | |
CN110812419A (zh) | 一种固肾强腰的黑参丸和制备方法 | |
CN103610076A (zh) | 一种海参胶囊的制造方法 | |
CN103053767A (zh) | 一种苁蓉保健营养茶制备方法 | |
CN104783174A (zh) | 一种纯天然营养免疫保健固体饮料的配制方法 | |
CN109123621A (zh) | 一种可调节机体免疫功能抑制血糖升高的保健食品 | |
CN104397282A (zh) | 一种安神补脑的刺五加保健茶及其制备方法 | |
CN108056461B (zh) | 一种黑木耳润肠功能咀嚼片及其制备方法 | |
CN113826882A (zh) | 防治糖尿病的膳食营养补充剂及其制备工艺 | |
CN113499416A (zh) | 一种补肝益肾组合物及其制备方法 | |
CN114748583A (zh) | 一种滋补养生的中药药酒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211015 |